Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study.

Chaoyong ShenChengshi WangTao HeZhaolun CaiXiaonan YinYuan YinDonghao LuBo ZhangZongguang Zhou

Published in: World journal of surgical oncology (2020)

AM-GISTs patients have decreased risk of dying from GISTs compared with GIST-1. Although another malignancy history does not seemingly affect OS for GISTs patients, clinical treatment of such patients should be cautious.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
smoking cessation